Professor Georgina Long hands on baton of SMR Presidency
31 October 2020
MIA’s Co-Medical Director, Professor Georgina Long AO, has passed the baton after two years as President of the Society for Melanoma Research (SMR). The US-based SMR is the world’s largest association of melanoma researchers and scientists. Professor Long was the first Australian and first female President of SMR, her election testament to her international standing as one of the world’s pre-eminent melanoma clinicians and researchers.
The annual 2020 SMR Melanoma Congress, scheduled to be held in New Orleans, was postponed due to the impact of COVID-19. Instead, a Virtual Congress was held during which Professor Long handed over the Presidency to Professor Ashani Weeraratna from Johns Hopkins School of Medicine.
In a message to SMR members, Professor Long said, ‘ The COVID-19 pandemic has presented a major challenge for all of us across the world, and we stand united in limiting the impact of the virus on our health, productivity and goals.’
Professor Long cites as a highlight of her 2-year Presidency, the phenomenal research output by SMR members who have continued to lead the cancer field despite the impact of COVID-19.
‘Despite not being able to gather in person, as we usually do annually, we connected virtually from around the world to share our knowledge and continue our collaboration,’ Professor Long said. ‘Importantly, we highlighted the work of two fabulous researchers in the field who both received SMR Awards for their contributions – Stefani Spranger was awarded the Young Investigator Award and Yardena Samuels was awarded the Estela Medrano Award.
‘It has been an honour to lead SMR for the past two years, and I look forward to continued collaboration as we move ever closer to reaching our goal of zero deaths from melanoma,’ she said.
Toyota and country music fans invited to tip their hat to help tackle Australia's national cancer – melanoma
Melanoma Institute Australia has teamed up with the Toyota Country Music Festival 2018 in Tamworth!
MIA's dermatologist shares her knowledge with GPs on debunking myths and controversies on sunscreen.
Shannan Ponton thought he was invincible – he wasn’t. But his melanoma battle ended up saving more than his own life.
Researchers have demonstrated that immunotherapy is highly effective in treating a rare form of melanoma – a result that is surprising due to the nature of the tumour.
Innovation is helping to prevent melanoma developing in the first place.
Research from MIA is changing the way melanoma is managed worldwide and improving patient survival. Here are a few of our key highlights from this year.
A prestigious Fellowship has been awarded to fund research that will change the way melanoma treatment is assessed in the future.
New research from MIA has been published that forms the basis of the updated international guidelines for staging melanoma.
Professor William McCarthy AM has been awarded the Tom Reeve Award for Outstanding Contributions to Cancer Care.
Leading researchers from MIA have been acknowledged with three prestigious awards for excellence in melanoma research.
New research shows that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.
2018 will be bigger than ever, and a little bit different.
MIA's epidemiologist explains her new research on how country of residence should be considered when identifying melanoma risk.
Congratulations to our Conjoint Medical Directors, Professor Georgina Long and Professor Richard Scolyer, who have today been announced as Fellows of the Australian Academy of Health and Medical Sciences.
New research shows potentially deadly UV damage can appear decades earlier than you think.
Early lymph node check is saving lives in melanoma patients
We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.
More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.